Ventus Medical introduces Provent Sleep Apnea Therapy in Canada

Published on November 20, 2012 at 12:38 AM · No Comments

Ventus Medical is pleased to announce the introduction of its proprietary Provent® Sleep Apnea Therapy into Canada. Provent Therapy is an innovative, non-invasive treatment for obstructive sleep apnea (OSA). Provent Therapy is now available in the province of Ontario and will be available throughout Canada by June 2013. ioSleep, Inc. is the strategic distribution partner of Provent Therapy in Canada.

There is growing demand for clinically proven sleep apnea treatments and the introduction of Provent represents a scientifically validated, innovative and user-friendly approach. Provent works across mild, moderate, and severe OSA and utilizes nasal expiratory positive airway pressure (EPAP) to keep a patient's airway open during sleep.

"According to the Public Health Agency of Canada over 1 in 4 Canadian adults are at high risk of having OSA.  OSA is suspected in patients who are loud snorers, excessively sleepy, obese and hypertensive," said Dr. John Fleetham, Professor of Medicine at the University of British Columbia. "OSA is increasingly being recognised in Canadian patients.  CPAP (continuous positive airway pressure) is the primary treatment for OSA, however not all patients can tolerate it as a long term treatment." Dr. Fleetham further comments, "I welcome new validated treatment alternatives for OSA such as Provent Sleep Apnea Therapy."

"We believe clinically-proven Provent Therapy offers a unique and convenient alternative to CPAP treatment for the large number of people in Canada currently affected by OSA," said Philip Westbrook, M.D., chief medical officer of Ventus Medical. "Provent has been used effectively in the United States since 2008 and in clinical studies, Provent Therapy improved quality of sleep while it reduced apnea (breathing disruptions), daytime sleepiness and snoring. Importantly, Provent is easy to use, portable and discreet for use at home or when travelling."

CPAP is the primary treatment of OSA and is extremely effective if worn as directed. However, up to half of all patients are not compliant with CPAP therapy due to the cumbersome nature of the treatment. Provent Therapy was developed to help patients who cannot tolerate CPAP therapy and will benefit from the small, non-invasive and effective technology, which Provent Therapy provides.

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post